Adhesive Capsulitis Secondary to COVID-19 Vaccination - A Case Series.
COVID-19 vaccines
adhesive capsulitis
shoulder joint
Journal
Malaysian orthopaedic journal
ISSN: 1985-2533
Titre abrégé: Malays Orthop J
Pays: Malaysia
ID NLM: 101564672
Informations de publication
Date de publication:
Jul 2023
Jul 2023
Historique:
received:
25
06
2022
accepted:
23
03
2023
medline:
16
8
2023
pubmed:
16
8
2023
entrez:
16
8
2023
Statut:
ppublish
Résumé
Shoulder injury related to vaccine administration (SIRVA) is a group of pathologies defined by pain and stiffness after intramuscular administration of vaccine to the upper arm and has been reported after COVID-19 vaccination. We aim to discuss its pathophysiology, clinical presentation, treatment and outcomes. We retrospectively identified patients presenting with adhesive capsulitis within four weeks of administration of COVID-19 vaccine to the affected arm at our tertiary institution from March 2021 to December 2022. Based on the above criteria, we identified seven cases of adhesive capsulitis, comprising one male and six female patients, with average age of 60 years. We present initial symptoms, signs and the duration from when the vaccine was administered. We have highlighted our treatment strategies as well as the clinical and functional outcomes reported by these patients after treatment. We have reported improvement in both Visual Analogue Scale (VAS) and range of motion (ROM) in all our patients after non-surgical management which included physiotherapy and, in some cases, hydrodilatation. SIRVA related adhesive capsulitis is rare and under-reported with limited information in current literature. This study highlights that adhesive capsulitis is a potential complication arising from improper COVID-19 vaccine administration and reinforces traditional wisdom of administering vaccinations on the non-dominant arm. Conservative treatment strategies appear to be effective, particularly hydrodilatation combined with physiotherapy, and patients are expected to have a good return of function.
Identifiants
pubmed: 37583521
doi: 10.5704/MOJ.2307.007
pmc: PMC10425003
doi:
Types de publication
Journal Article
Langues
eng
Pagination
43-48Informations de copyright
© 2023 Malaysian Orthopaedic Association (MOA). All Rights Reserved.
Déclaration de conflit d'intérêts
Each author certifies that neither he or she, nor any member of his or her immediate family, have funding or commercial associations (consultancies, stock ownership, equity interest, patent/licensing arrangements, etc) that might pose a conflict of interest in connection with the submitted article.
Références
Lancet Infect Dis. 2021 Jul;21(7):939-949
pubmed: 33930320
Radiol Case Rep. 2021 Dec;16(12):3631-3634
pubmed: 34611469
Ann Med Surg (Lond). 2021 Sep;69:102819
pubmed: 34512965
Vaccine. 2015 Nov 17;33(46):6152-5
pubmed: 26458794
Clin Orthop Surg. 2019 Sep;11(3):249-257
pubmed: 31475043
Workplace Health Saf. 2021 Feb;69(2):68-72
pubmed: 32967588
Vaccine. 2017 Sep 5;35(37):4870-4876
pubmed: 28774564
Ann Med Surg (Lond). 2021 Aug;68:102622
pubmed: 34336204
Hum Vaccin Immunother. 2015;11(5):1184-91
pubmed: 25868476
J Am Board Fam Med. 2012 Nov-Dec;25(6):919-22
pubmed: 23136333
Vaccine. 2007 Jan 8;25(4):585-7
pubmed: 17064824
World J Orthop. 2015 Mar 18;6(2):263-8
pubmed: 25793166
J Shoulder Elbow Surg. 2011 Mar;20(2):322-5
pubmed: 21051244
Vaccine. 2012 Dec 17;31(1):27-30
pubmed: 23122992
Skeletal Radiol. 2021 Nov;50(11):2293-2297
pubmed: 33944967
Vaccine. 2020 Jan 29;38(5):1137-1143
pubmed: 31784231
Cochrane Database Syst Rev. 2003;(2):CD004258
pubmed: 12804509
Rev Bras Ortop (Sao Paulo). 2021 Jun;56(3):299-306
pubmed: 34239193
Vaccine. 2010 Nov 29;28(51):8049-52
pubmed: 20955829